SEC Filing Summary: Palisade Bio, Inc. (PALI)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Palisade Bio, Inc. on April 28, 2021. The filing serves as a Regulation FD disclosure to announce an upcoming conference call and webcast scheduled for 11:00 a.m. ET on the same date. The company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol PALI.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a corporate presentation and does not contain audited financial statements or quarterly results.
Material Changes
No material changes to financial performance or operations are reported in this specific filing. The document solely references the attachment of a corporate presentation (Exhibit 99.1) which contains the substantive information to be discussed.
Guidance, Outlook, and Risks
Management commentary, guidance, and risk factors are contained within the attached corporate presentation (Exhibit 99.1) rather than the body of this 8-K. The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section nor incorporated by reference into other filings unless specifically stated by the company.
Key Facts for Investor Verification
- Verify the content of the attached corporate presentation (Exhibit 99.1) for actual financial data and strategic updates.
- Confirm the archived webcast and presentation are available on the company website (www.palisadebio.com).
- Note that the information in this filing is not incorporated by reference into other SEC filings by default.
- Check the company's status as an emerging growth company, as indicated by the checked box in the filing header.